| 标题 |
UPLIFT (ENGOT-OV67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin (UpRi; XMT-1536), a NaPi2b-directed dolaflexin antibody-drug conjugate in platinum-resistant ovarian cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gynecologic Oncology 作者:Debra Richardson; Nicole Concin; John Hays; Jose Alejandro Perez Fidalgo; Bhavana Pothuri; et al 出版日期:2024-10-09 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)